These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 39050521
1. Triglyceride Glucose Body Mass Index as 3 Year Prognostic Indicator for Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Acute Myocardial Infarction After PCI: A Prospective Cohort Study. Yang Y, Wang Y, Pei XY. Clin Interv Aging; 2024; 19():1341-1350. PubMed ID: 39050521 [Abstract] [Full Text] [Related]
2. Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C≤1.8 mmol/L who underwent percutaneous coronary intervention: a prospective cohort study. Zhao HW, Wang Y, Wang CF, Meng QK. Front Endocrinol (Lausanne); 2023; 14():1323615. PubMed ID: 38313836 [Abstract] [Full Text] [Related]
3. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Cardiovasc Diabetol; 2023 Mar 30; 22(1):75. PubMed ID: 36997935 [Abstract] [Full Text] [Related]
4. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. Cardiovasc Diabetol; 2019 Nov 13; 18(1):150. PubMed ID: 31722708 [Abstract] [Full Text] [Related]
5. Multiple triglyceride-derived metabolic indices and incident cardiovascular outcomes in patients with type 2 diabetes and coronary heart disease. Tao S, Yu L, Li J, Huang L, Xue T, Yang D, Huang X, Meng C. Cardiovasc Diabetol; 2024 Oct 14; 23(1):359. PubMed ID: 39402572 [Abstract] [Full Text] [Related]
6. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao XQ, Li W, Li H. Cardiovasc Diabetol; 2021 Feb 11; 20(1):43. PubMed ID: 33573649 [Abstract] [Full Text] [Related]
7. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Tao S, Yu L, Li J, Xie Z, Huang L, Yang D, Tan Y, Zhang W, Huang X, Xue T. Cardiovasc Diabetol; 2023 Nov 28; 22(1):322. PubMed ID: 38017540 [Abstract] [Full Text] [Related]
8. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention. Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. Front Endocrinol (Lausanne); 2021 Nov 28; 12():710240. PubMed ID: 34489866 [Abstract] [Full Text] [Related]
9. The Prognostic Value of the Triglyceride-Glucose Index in Forecasting Ten-Year Major Adverse Cardiovascular Events in Non-Diabetic Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Köktürk U, Onalan O, Somuncu MU, Uygur B, Erbay İ, Çakan F, Avcı A. Turk Kardiyol Dern Ars; 2024 Jun 28; 52(4):253-259. PubMed ID: 38829642 [Abstract] [Full Text] [Related]
10. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H. Cardiovasc Diabetol; 2021 Jun 28; 20(1):131. PubMed ID: 34183007 [Abstract] [Full Text] [Related]
11. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Song Y, Cui K, Yang M, Song C, Yin D, Dong Q, Gao Y, Dou K. Cardiovasc Diabetol; 2023 Jul 15; 22(1):180. PubMed ID: 37454147 [Abstract] [Full Text] [Related]
13. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome. Wang C, Liao P, Tang C, Chen C, Zhang X. Front Endocrinol (Lausanne); 2024 Jul 15; 15():1423227. PubMed ID: 39257901 [Abstract] [Full Text] [Related]
18. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study. Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Cardiovasc Diabetol; 2023 Jun 29; 22(1):161. PubMed ID: 37386494 [Abstract] [Full Text] [Related]
19. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention. Xiong S, Chen Q, Zhang Z, Chen Y, Hou J, Cui C, Cheng L, Su H, Long Y, Yang S, Qi L, Chen X, Liu H, Cai L. Cardiovasc Diabetol; 2022 Jun 24; 21(1):115. PubMed ID: 35751060 [Abstract] [Full Text] [Related]
20. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Xiong S, Chen Q, Chen X, Hou J, Chen Y, Long Y, Yang S, Qi L, Su H, Huang W, Liu H, Zhang Z, Cai L. Cardiovasc Diabetol; 2022 Aug 05; 21(1):145. PubMed ID: 35932019 [Abstract] [Full Text] [Related] Page: [Next] [New Search]